Related Experiment Video
Updated: Jul 15, 2026

11:34
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
[Aptamers as perspective affine reagents for clinical proteomics]
Biomeditsinskaia Khimiia
|April 18, 2007
Summary
Oligonucleotide aptamers offer a cost-effective, automatable alternative to antibodies for scientific and medical applications. This review explores optimizing aptamer selection and modification for enhanced protein targeting.
Area of Science:
- Biotechnology
- Molecular Biology
- Chemical Biology
Context:
- Advancements in affine microchip technology are crucial for applying proteomic findings in medicine.
- Monoclonal antibodies face limitations, driving the search for alternative affinity reagents.
- Synthetic antibody mimetics, particularly oligonucleotide aptamers, are gaining interest.
Purpose:
- To review challenges and strategies in the automation and optimization of aptamer selection.
- To discuss the selection and application of photoaptamers for covalent protein complex formation.
- To explore post-selection aptamer modification techniques for improved affinity and selectivity.
Summary:
- Oligonucleotide aptamers are synthetic reagents with potential to replace antibodies due to automated selection and low synthesis cost.
- The review covers automated aptamer selection, optimization, and the development of photoaptamers for photo-induced covalent binding.
- Methods for enhancing aptamer affinity and selectivity through post-selection modification are also discussed.
Impact:
- Facilitates the development of novel diagnostic and therapeutic tools based on aptamer technology.
- Enables more efficient and cost-effective protein detection and analysis in research and clinical settings.
- Advances the application of proteomics in scientific and medical practice through improved affinity reagents.

